Advertisement
U.S. markets open in 23 minutes
  • S&P Futures

    5,307.50
    -0.75 (-0.01%)
     
  • Dow Futures

    40,178.00
    +34.00 (+0.08%)
     
  • Nasdaq Futures

    18,491.50
    -12.25 (-0.07%)
     
  • Russell 2000 Futures

    2,142.20
    +3.80 (+0.18%)
     
  • Crude Oil

    82.68
    +1.33 (+1.63%)
     
  • Gold

    2,233.20
    +20.50 (+0.93%)
     
  • Silver

    24.77
    +0.02 (+0.09%)
     
  • EUR/USD

    1.0817
    -0.0013 (-0.12%)
     
  • 10-Yr Bond

    4.2140
    +0.0180 (+0.43%)
     
  • Vix

    12.97
    +0.19 (+1.49%)
     
  • GBP/USD

    1.2644
    +0.0006 (+0.05%)
     
  • USD/JPY

    151.2200
    -0.0260 (-0.02%)
     
  • Bitcoin USD

    70,756.66
    -22.56 (-0.03%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,957.16
    +25.18 (+0.32%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

AbbVie CEO not ruling out hostile move on Shire

LONDON, June 25 (Reuters) - U.S. drugmaker AbbVie declined to rule out a hostile bid for Shire on Wednesday but said it was pushing hard for the London-listed drugmaker to engage in talks, after its $46 billion takeover approach was rejected.

Questioned by analysts if he might make a hostile bid, Chief Executive Richard Gonzalez said on conference call: "We're not willing to restrict our legal options here." He declined to comment on what approach AbbVie might take if it went down a hostile path.

Gonzalez stressed he wanted to engage with Shire's management to better understand its upbeat drug sales forecasts, adding he also planned to meet with Shire shareholders.

(Reporting by Ben Hirschler; editing by Kate Holton)

Advertisement